Completed OBSERVATIONAL NCT05946928

EMERGENCE AGITATION After Premedication IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY (premidazolam)

CLINICAL EVALUATION AND IMPACT ON EMERGENCE AGITATION OF AN ORAL SOLUTION OF MIDAZOLAM CONTAINING g-CICLODEXSTRIN IN PAEDIATRIC MAGNETIC RESONANCE IMAGING: A RETROSPECTIVE COHORT STUDY

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions Autism Spectrum Disorder Brain Neoplasms Brain Pathology Growth Retardation Premedication

Updated 3 times since 2023 Last updated: Jul 14, 2023 Started: Mar 1, 2022 Primary completion: Dec 15, 2022 Completion: Dec 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Autism Spectrum Disorder and Brain Neoplasms, this trial is completed. The trial is conducted by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and has accumulated 3 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Aug 2023 — Jul 2024 [monthly]

Completed

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Data source: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy